Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sight Sciences (SGHT) Amortization of Deferred Charges (2020 - 2025)

Sight Sciences (SGHT) has 6 years of Amortization of Deferred Charges data on record, last reported at $230000.0 in Q4 2025.

  • For Q4 2025, Amortization of Deferred Charges rose 13.3% year-over-year to $230000.0; the TTM value through Dec 2025 reached $944000.0, up 25.37%, while the annual FY2025 figure was $944000.0, 25.37% up from the prior year.
  • Amortization of Deferred Charges reached $230000.0 in Q4 2025 per SGHT's latest filing, down from $249000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $382000.0 in Q3 2024 and bottomed at $74000.0 in Q2 2024.
  • Average Amortization of Deferred Charges over 5 years is $183450.0, with a median of $170000.0 recorded in 2021.
  • Peak YoY movement for Amortization of Deferred Charges: crashed 50.67% in 2024, then surged 220.27% in 2025.
  • A 5-year view of Amortization of Deferred Charges shows it stood at $170000.0 in 2021, then dropped by 8.82% to $155000.0 in 2022, then increased by 4.52% to $162000.0 in 2023, then grew by 25.31% to $203000.0 in 2024, then grew by 13.3% to $230000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Amortization of Deferred Charges were $230000.0 in Q4 2025, $249000.0 in Q3 2025, and $237000.0 in Q2 2025.